{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:45:51Z","timestamp":1789469151995,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["291799"],"award-info":[{"award-number":["291799"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["749058"],"award-info":[{"award-number":["749058"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["TC144"],"award-info":[{"award-number":["TC144"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["TC256"],"award-info":[{"award-number":["TC256"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.drup.2025.101213","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T17:08:13Z","timestamp":1739639293000},"page":"101213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Sanfetrinem, an oral \u03b2-lactam antibiotic repurposed for the treatment of tuberculosis"],"prefix":"10.1016","volume":"80","author":[{"given":"Santiago","family":"Ram\u00f3n-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Gonz\u00e1lez del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4852-6130","authenticated-orcid":false,"given":"Mar\u00eda Pilar","family":"Arenaz-Callao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-206X","authenticated-orcid":false,"given":"Helena I.","family":"Boshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Rullas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Anca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Cacho Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Porras de Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"P\u00e9rez Herr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Santos-Villarejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-4118","authenticated-orcid":false,"given":"Alfonso","family":"Mendoza-Losana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ferrer-Bazaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barros Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1926-8114","authenticated-orcid":false,"given":"Robert H.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drup.2025.101213_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO's global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.drup.2025.101213_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1473-3099(21)00470-9","article-title":"Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study","volume":"22","author":"Ismail","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.drup.2025.101213_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/acsinfecdis.1c00570","article-title":"Identification of \u03b2-lactams active against Mycobacterium tuberculosis by a consortium of pharmaceutical companies and academic institutions","volume":"8","author":"Gold","year":"2022","journal-title":"ACS Infect. Dis."},{"issue":"3","key":"10.1016\/j.drup.2025.101213_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/path.1700580320","article-title":"The effect of penicillin on the tubercle bacillus","volume":"58","author":"Iland","year":"1946","journal-title":"J. Pathol. Bacteriol."},{"issue":"2","key":"10.1016\/j.drup.2025.101213_bib5","first-page":"95","article-title":"Penicillin: the robert campbell oration","volume":"13","author":"Fleming","year":"1944","journal-title":"Ulst. Med. J."},{"issue":"5","key":"10.1016\/j.drup.2025.101213_bib6","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/AAC.41.5.1182","article-title":"Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra","volume":"41","author":"Hackbarth","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.drup.2025.101213_bib7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1021\/acsinfecdis.8b00160","article-title":"Pharmacokinetics of \u03b2-lactam antibiotics: clues from the past to help discover long-acting oral drugs in the future","volume":"4","author":"Smith","year":"2018","journal-title":"ACS Infect. Dis."},{"issue":"8","key":"10.1016\/j.drup.2025.101213_bib8","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1128\/AAC.00665-12","article-title":"Inactivation of Mycobacterium tuberculosis L, D-transpeptidase LdtMt1 by carbapenems and cephalosporins","volume":"56","author":"Dub\u00e9e","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5918","key":"10.1016\/j.drup.2025.101213_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1167498","article-title":"Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis","volume":"323","author":"Hugonnet","year":"2009","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.drup.2025.101213_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nm.2120","article-title":"The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin","volume":"16","author":"Gupta","year":"2010","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.drup.2025.101213_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/ijms17030373","article-title":"Carbapenems to treat multidrug and extensively drug-resistant tuberculosis: a systematic review","volume":"17","author":"Sotgiu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.drup.2025.101213_bib12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5588\/ijtld.16.0498","article-title":"Carbapenems against Mycobacterium tuberculosis: a review of the evidence","volume":"20","author":"Jaganath","year":"2016","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"43","key":"10.1016\/j.drup.2025.101213_bib13","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1021\/bi701506h","article-title":"Irreversible inhibition of the Mycobacterium tuberculosis \u03b2-lactamase by clavulanate","volume":"46","author":"Hugonnet","year":"2007","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.drup.2025.101213_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMc1513236","article-title":"\u03b2-Lactams against tuberculosis\u2014new trick for an old dog?","volume":"375","author":"Diacon","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.drup.2025.101213_bib15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1183\/13993003.02146-2015","article-title":"Effectiveness and safety of meropenem\/clavulanate-containing regimens in the treatment of MDR-and XDR-TB","volume":"47","author":"Tiberi","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.drup.2025.101213_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5588\/ijtld.11.0414","article-title":"Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study","volume":"16","author":"Payen","year":"2012","journal-title":"Int. J. Tuberc. lung Dis."},{"issue":"22","key":"10.1016\/j.drup.2025.101213_bib17","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/S0960-894X(96)00515-X","article-title":"Synthesis and antibacterial, activity of 4-ureido trinems","volume":"6","author":"G\u00e9hanne","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.drup.2025.101213_bib18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/AAC.40.5.1248","article-title":"In vitro activity of the tricyclic beta-lactam GV104326","volume":"40","author":"Wise","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"14","key":"10.1016\/j.drup.2025.101213_bib19","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0960-894X(96)00292-2","article-title":"Synthesis and antimicrobial activity of 4-amino trinems","volume":"6","author":"Tranquillini","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.drup.2025.101213_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/AAC.01920-15","article-title":"Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages","volume":"60","author":"Sorrentino","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.drup.2025.101213_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tube.2010.12.007","article-title":"Deciphering the role of IS6110 in a highly transmissible Mycobacterium tuberculosis Beijing strain, GC1237","volume":"91","author":"Alonso","year":"2011","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.drup.2025.101213_bib22","doi-asserted-by":"crossref","first-page":"34293","DOI":"10.1038\/srep34293","article-title":"Repurposing clinically approved cephalosporins for tuberculosis therapy","volume":"6","author":"Ram\u00f3n-Garc\u00eda","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.drup.2025.101213_bib23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/21505594.2015.1044195","article-title":"The mycobacterial P55 efflux pump is required for optimal growth on cholesterol","volume":"6","author":"Ram\u00f3n-Garc\u00eda","year":"2015","journal-title":"Virulence"},{"issue":"8","key":"10.1016\/j.drup.2025.101213_bib24","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/AAC.00474-11","article-title":"Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen","volume":"55","author":"Ram\u00f3n-Garc\u00eda","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.drup.2025.101213_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijmyco.2014.09.002","article-title":"Resazurin microtiter assay for isoniazid, rifampicin, ethambutol and streptomycin resistance detection in Mycobacterium tuberculosis: updated meta-analysis","volume":"3","author":"Coban","year":"2014","journal-title":"Int. J. Mycobacteriol."},{"issue":"1","key":"10.1016\/j.drup.2025.101213_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2014.11.016","article-title":"Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms","volume":"17","author":"Manina","year":"2015","journal-title":"Cell host Microbe"},{"issue":"8","key":"10.1016\/j.drup.2025.101213_bib27","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1128\/AAC.01063-15","article-title":"Combinations of \u03b2-lactam antibiotics currently in clinical trials are efficacious in a DHP-I-deficient mouse model of tuberculosis infection","volume":"59","author":"Rullas","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2025.101213_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.677005","article-title":"Cefdinir and \u03b2-lactamase inhibitor independent efficacy against Mycobacterium tuberculosis","volume":"12","author":"Srivastava","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.drup.2025.101213_bib29","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1073\/pnas.0605728104","article-title":"A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages","volume":"104","author":"Van der Geize","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.drup.2025.101213_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/45.2.159","article-title":"Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis","volume":"45","author":"Piddock","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.drup.2025.101213_bib31","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1128\/AAC.01824-10","article-title":"Activity of carbapenems combined with clavulanate against murine tuberculosis","volume":"55","author":"Veziris","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.drup.2025.101213_bib32","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1128\/AAC.05690-11","article-title":"Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo","volume":"56","author":"England","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.drup.2025.101213_bib33","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1128\/AAC.00023-13","article-title":"In vitro and in vivo efficacy of \u03b2-lactams against replicating and slowly growing\/nonreplicating Mycobacterium tuberculosis","volume":"57","author":"Solapure","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.drup.2025.101213_bib34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1164\/rccm.202108-1976OC","article-title":"Early bactericidal activity of meropenem plus clavulanate (with or without rifampin) for tuberculosis: the COMRADE randomized, phase 2A clinical trial","volume":"205","author":"Jager","year":"2022","journal-title":"Am. J. Respir. Crit. care Med."},{"issue":"14","key":"10.1016\/j.drup.2025.101213_bib35","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0960-894X(97)00326-0","article-title":"Tricyclic \u03b2-lactams: Total synthesis and antibacterial activity of 5\u03b1-methoxyethyl and 5\u03b1-hydroxyethyl trinems","volume":"7","author":"Hanessian","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.drup.2025.101213_bib36","doi-asserted-by":"crossref","first-page":"9780","DOI":"10.1021\/jp044192m","article-title":"Molecular modeling and chemical reactivity of sanfetrinem and derivatives","volume":"109","author":"Fasoli","year":"2005","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.drup.2025.101213_bib37","unstructured":"Prezelj, A., Urleb, U., Vilfan, G., 2011. Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics. 2011, Google Patents.."},{"issue":"9","key":"10.1016\/j.drup.2025.101213_bib38","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1128\/AAC.40.9.2142","article-title":"In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms","volume":"40","author":"Singh","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.drup.2025.101213_bib39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.12.96","article-title":"Reappraising the use of \u03b2-lactams to treat tuberculosis","volume":"10","author":"Kurz","year":"2012","journal-title":"Expert Rev. anti-Infect. Ther."},{"issue":"7","key":"10.1016\/j.drup.2025.101213_bib40","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.42.7.1745","article-title":"Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae","volume":"42","author":"Cuffini","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.drup.2025.101213_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jac\/42.2.249","article-title":"Sub-MICs of sanfetrinem promote the interaction of human polymorphonuclear granulocytes with a multiply resistant strain of Klebsiella pneumoniae","volume":"42","author":"Cuffini","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.drup.2025.101213_bib42","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1128\/AAC.02924-15","article-title":"Susceptibility testing of antibiotics that degrade faster than the doubling time of slow-growing mycobacteria: ertapenem sterilizing effect versus Mycobacterium tuberculosis","volume":"60","author":"Srivastava","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.drup.2025.101213_bib43","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.41.10.2173","article-title":"Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and-resistant pneumococci","volume":"41","author":"Spangler","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.drup.2025.101213_bib44","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/AAC.03461-14","article-title":"Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable \u03b2-lactam antibiotic","volume":"59","author":"Dhar","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.drup.2025.101213_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ncomms1060","article-title":"A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy","volume":"1","author":"Pethe","year":"2010","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.drup.2025.101213_bib46","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1128\/AAC.42.5.1168","article-title":"Interactions of \u03b2-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral \u03b2-lactams","volume":"42","author":"Babini","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2025.101213_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ebiom.2016.05.041","article-title":"Paradoxical Hypersusceptibility of Drug-resistant Mycobacterium tuberculosis to \u03b2-lactam Antibiotics","volume":"9","author":"Cohen","year":"2016","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.drup.2025.101213_bib48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/jac\/dks395","article-title":"Is there a place for \u03b2-lactams in the treatment of multidrug-resistant\/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin\/clavulanate","volume":"68","author":"Gonzalo","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.drup.2025.101213_bib49","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1128\/AAC.01158-15","article-title":"Carbapenems and rifampin exhibit synergy against Mycobacterium tuberculosis and Mycobacterium abscessus","volume":"59","author":"Kaushik","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.drup.2025.101213_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nchembio.2237","article-title":"Non-classical transpeptidases yield insight into new antibacterials","volume":"13","author":"Kumar","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.drup.2025.101213_bib51","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jmii.2015.08.025","article-title":"Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin\/clavulanate combination","volume":"49","author":"Pagliotto","year":"2016","journal-title":"J. Microbiol., Immunol. Infect."},{"issue":"1","key":"10.1016\/j.drup.2025.101213_bib52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s13063-022-06473-9","volume":"23","author":"Johnson","year":"2022","journal-title":"Trials"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:06:42Z","timestamp":1778605602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"alternative-id":["S1368764625000135"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101213","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.10.617558","asserted-by":"object"}]},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sanfetrinem, an oral \u03b2-lactam antibiotic repurposed for the treatment of tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101213"}}